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Abstract
Background: Mild cases of malaria, pneumonia and diarrhea are readily treatable with complete recovery and with
inexpensive and widely available first-line drugs. However, treatment is complicated and expensive, and mortality is
higher when children present to the hospital with severe forms of these illnesses. We studied how care seeking
behaviours and other factors contributed to severity of malaria, pneumonia and diarrhoea among children less than
five years in rural Tanzania.
Methods: We interviewed consecutive care-takers of children diagnosed with malaria, pneumonia and/or diarrhea
at Korogwe and Muheza district hospitals, in north-eastern Tanzania, between July 2009 and January 2010, and
compared characteristics of children presenting with severe and those with non-severe disease.
Results: A total of 293 children with severe and 190 with non-severe disease were studied. We found persistent
associations between severity of disease and caretaker’s lack of formal education (OR 6.6; 95% confidence interval (CI)
2.7-15.8) compared to those with post-primary education, middle compared to high socio-economic status (OR 1.9;
95% CI 1.2-3.2), having 4 or more children compared to having one child (OR 2.5; 95% CI 1.4-4.5), having utilized a
nearer primary health care (PHC) facility for the same illness compared to having not (OR 5.2; 95% CI 3.0-9.1), and
having purchased the first treatment other than paracetamol from local or drug shops compared to when the
treatment was obtained from the public hospitals for the first time (OR 3.2; 95% CI 1.9-5.2). The old officially abandoned
first line anti-malaria drug Sulfadoxin-pyrimethamine (SP) was found to still be in use for the treatment of malaria and
was significantly associated with childrens’ presentation to the hospital with severe malaria (OR 12.5; 95% CI 1.6-108.0).
Conclusions: Our results indicate that caretakers with no formal education, with lower SES and with many children
can be target groups for interventions in order to further reduce child mortality from treatable illnesses. Furthermore,
the quality of the available drug shops and PHC facilities need to be closely monitored.
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Background
Mild cases of malaria, pneumonia and diarrhea are
treatable with complete recovery from the widely
available and inexpensive first line drugs. However,
the three diseases still account for the majority of
child deaths among children between one month and
five years of age in sub-Saharan Africa, including Tan-
zania [1,2]. Mortality is higher when children present
to the hospital with severe compared to mild forms
of these illnesses [3,4]. In one of the studies, con-
ducted among children admitted to a Pediatric Emer-
gency Room in India, it was found that the case
fatality rates for non-severe, severe and very severe
pneumonia were 0%, 8.7% and 47.0% respectively [4].
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There have been many efforts to prevent infections in
children through vaccination programmes and other
community interventions, some with success. One ex-
ample is the reduction of malaria incidence following
the wide distribution of insecticide-treated mosquito
nets [5,6]. However, primary prevention of infectious
diseases is still difficult to achieve particularly for chil-
dren in poor families who are continuously exposed to
health risks and other hazards typical in poor communi-
ties. In addition, many children from poor families are
undernourished, making them less resistant to infec-
tions. This makes early disease detection and timely
management crucial in preventing deaths of these chil-
dren from treatable illnesses.
There has been an unacceptable widening gap in child
mortality between rich and poor countries as well as be-
tween wealthy and poor children within many countries
(9). Within countries child mortality is often higher in
rural areas, and among the poor and less educated fam-
ilies [7,8]. These inequities are compounded by the
reduced access to available preventive and curative inter-
ventions by children from poor families. Public subsidies
for health services frequently benefit rich people more
than the poor [8]. Health interventions targeting children
from poor families may significantly contribute to further
reduction in child mortality from treatable illnesses.
We wanted to know what characterizes children who
are more likely to develop severe disease from malaria,
pneumonia and diarrhoea. Hence, we conducted a hos-
pital based cross-sectional survey in two predominantly
rural districts of Tanzania, and compared children pre-
senting at two district hospitals with severe from those
presenting with mild forms of malaria, pneumonia and
diarrhoea. Our main objective was to assess determi-
nants of severe disease, particularly health care seeking
factors, among under-five children in the study area.
Methods
Study area
The study was conducted at Korogwe and Muheza dis-
trict hospitals of Tanga Region in north-eastern Tanza-
nia. The two hospitals serve as referral hospitals in the
two districts. Korogwe district is located about 100 km
inland from Tanga. Based on the 2002 Census and a
population growth rate of 1.2% per year [9], the pro-
jected population in 2009 was 282,901. The district is
served by 47 dispensaries, four health centres, one dis-
trict hospital and two church owned hospitals. Muheza
district is around 25 km from the city of Tanga and is
about 70 km from Korogwe. Based on 2002 census and
a population growth rate of 1.4%, it had a projected
population of 306,862 in 2009 [9], which is served by 54
dispensaries, four health centres, and one district hos-
pital. The two districts are predominantly rural and the
people are mainly subsistence farmers of maize, cassava,
oranges, coconut, rice and banana. Malaria is the leading
cause of admissions and deaths among under-five chil-
dren in both districts [10,11].
Study design and sample size
This was a cross-sectional hospital based survey among
care-takers who brought their sick children at Korogwe
and Muheza district hospitals. The target population was
care-takers of children between 1 month and 5 years,
with a diagnosis of malaria, pneumonia or diarrhoea seen
at the outpatient clinics in the two hospitals. In order to
detect a difference of 15% in risk of having severe disease,
assuming that the risk factor is present in 35% severe and
20% non-severe cases, granted 80% statistical power and
a 95% confidence level, we needed at least 296 cases.
Data collection
Data was collected between July 2009 and January 2010.
We identified all sick children presenting with symptoms
suggestive of our diseases of interest to the outpatient
department between 09am and 02pm i.e. fever, cough,
difficult or fast breathing, diarrhoea and vomiting. These
were reviewed and assigned diagnosis as per WHO
guidelines [12] by the principal investigator or a trained
clinical officer. Children with a diagnosis of malaria,
pneumonia or diarrhoea were included in the study.
While the diagnosis of pneumonia and diarrhoea was
reached clinically, malaria diagnosis was confirmed with
a rapid malaria diagnostic test (ParacheckW).
Interviews were conducted by trained clinical officers
after obtaining a written informed consent. Children who
did not need admission were interviewed in a room
located near the outpatient department while caretakers
of children who were admitted to the hospital were inter-
viewed later within their respective wards, after the child
had received initial treatment. The information collected
included care-seeking information with all treatments
received and places they were obtained from, availability
and use of primary care facilities and referral information.
Other information collected included questions about
indicators of socio-economic status such as household
characteristics, composition and assets. All children were
also assessed for weight and mid-upper arm circumfer-
ence (measured at the mid-point between the tip of the
shoulder and the tip of the elbow). Caretakers of fifteen
severely ill children who died before the interviews could
be conducted were not included.
Ethical consideration
Ethical approval was obtained from the National Insti-
tute for Medical Research in Tanzania. Prior to conduct-
ing the interviews, informed written consent was
obtained from all caretakers for their participation and
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participation of their children, and none refused. All
study procedures were conducted with caution not to
interfere with the patients’ ordinary consultations and
only after the child had initiated all the necessary
treatment.
Data analysis
Data was double-entered and validated using Epidata
version 3.1 and SPSS version 18 was used for analysis.
Severe disease included all children with one or more of
the following diagnoses: severe malaria, severe and very
severe pneumonia, and acute watery diarrhoea (AWD)
with some and with severe dehydration. Mild disease
included non-severe malaria, mild pneumonia and AWD
with no dehydration. We performed bivariate analysis to
examine associations between child’s disease severity sta-
tus and potential predictors. Multivariate analyses were
used to determine predictors that remained associated
with severe disease when adjusted for other factors. The
variables selected for the multivariate model were either
significant (p-value <0.05) in the bivariate analysis or
shown to be significant in previously published studies.
Results
We completed interviews with 560 caretakers of children
with a history of symptoms suggestive of malaria, pneu-
monia or diarrhoea. Out these children, 483 qualified for
one or more of above diagnoses and 293 were classified
as severe cases. Thirty seven children had more than one
diagnosis and if one or more of the diagnoses were severe
then the child was categorized as a severe case. Figure 1
summarises the proportion of children with the three
diseases together and their severity classification.
The number of study participants enrolled from each
district was fairly equal; 258 (53.7%) from Korogwe ver-
sus 225 (46.3%) from Muheza. Children were fairly
equally distributed by sex and 37% were below one year
(Table 1). The majority of caretakers had primary educa-
tion (75.8%) and were peasants (61.1%). Most caretakers
reported having two to three living children and 121
(25.1%) had experienced at least one child death (aged
less than five years) in the past.
We used logistic regression to explore any potential
associations between participants’ background character-
istics and severe disease in our sample of children
(Table 1). We found severe disease to be slightly more
common among younger compared to older children
(64.8% among infants versus 52.3% among children aged
two or more years) as well as among children with smal-
ler mid-upper arm circumference (70.6% among children
with MUAC between 8.0-13.9 cm compared to 53.7%
among those with MUAC of 15 cm and above). Care-
takers with no formal education had significantly higher
chances of presenting with a severely ill child compared
to those with primary and post-primary education
(82.1% versus 57.9% and 43.6% respectively). Risk of se-
vere disease was also positively associated with lower
socioeconomic status, increasing number of caretakers’
own alive children and increasing travel time from home
to the district (study) hospital (Table 1).
Almost all care-takers (442/483; 91.5%) had taken
some action within the first 24 hours after recognizing
the first child’s symptom. Fever was most frequently
reported to be among the first symptoms (61.7%), fol-
lowed by cough (44.5%). Diarrhea and vomiting was
reported to be among the first symptoms in 23.4% and
21.6% of children respectively. Convulsions was experi-
enced by 45 (9.3%) children but was only mentioned as
the first symptom in 15 (3.1%) children.
The first option of care for the majority (50.5%) was
giving treatment purchased from local and drug shops,
mainly paracetamol. A few (15.3%) had given treatments
available at home, commonly from previous consulta-
tions. Only 104 (21.5%) caretakers reported to have
taken their children to the public hospitals within the
first 24 hours of onset of symptoms.
Medications given at home were commonly leftovers
of previous consultations but were also reported to be
purchased from local shops. These included, apart from
paracetamol and oral rehydration fluid, tablets like
metronidazole, zinc, salbutamol, cotrimoxazole, and syr-
ups like quinine and amoxicillin. Drug shops had more
medications and also the specially-packed first line anti-
malaria drug (ALuW) that was only to be obtained from
public facilities at the time of data collection.
The majority of caretakers (60.5%) who reported not to
utilize their nearer PHC facilities had obtained their first
treatment other than paracetamol at the study hospital,
most of them (77.6%) within 1–2 days of onset of child’s








Figure 1 Distribution of children in relation to the three
diseases. SEVERE CASES: Malaria = 51, Pneumonia = 150,
Diarrhoea= 102.
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reported having utilized their nearer PHC facilities had
also obtained their first treatment, other than paracetamol,
from the public hospitals (PHC facility visited first or
study hospital). However, only 24.8% had received this
treatment within 1–2 days after the child got symptoms;
35.8% had received it on the 3rd or 4th day while the
remaining 39.4% got it on the 5th day or later.
Severe disease was more common among children
with longer symptoms duration and among children
who had utilized Primary Health Care (PHC) facilities
for the same illness (Table 2). Children who had received
treatments other than paracetamol for the same illness
before coming to the district hospital had a higher prob-
ability of presenting with severe disease as compared to
those who had received paracetamol only (67.9% versus
51.8%). Severe disease was also more common among
children who had obtained the first treatment other than
paracetamol from local sources or drug shops.
Table 3 below depicts results from multiple logistic re-
gression analysis to compare risk factors for disease sever-
ity in individual diseases. The findings indicate that
caretaker’s number of living children was strongly asso-
ciated with malaria severity while it was weakly associated
with diarrhoea severity and not with pneumonia severity.
Table 1 Multiple logistic regression of possible background risk factors for severe disease among studied children
(n =483)
Risk factor for disease severity Total cases** Severe disease cases (%) OR AOR
Child’s Sex
Female 230 146 (63.5) 1.3 (0.9-1.8) 1.3 (0.9-2.0)
Male 253 147 (58.1) ref ref
Child’s Age
0-11 months 179 116 (64.8) 1.7 (1.1-2.6)* 1.8 (1.1-2.8)*
12-23 months 131 87 (66.4) 1.8 (1.1-2.9)* 1.9 (1.1-3.0)*
24+ months 172 90 (52.3) ref ref
Child’s Weight
0-9.9 kg 253 169 (66.8) 1.8 (1.2-2.6)* 1.6 (0.9-3.0)
10.0-14.9 kg 204 109 (53.4) ref ref
15.0-20+ kg 22 12 (54.5) 1.0 (0.4-2.5) 1.2 (0.5-3.2)
Child’s MUAC
8.0-13.9 cm 160 113 (70.6) 2.1 (1.3-3.3)* 1.6 (1.0-2.6)*
14.0-14.9 cm 139 80 (57.6) 1.2 (0.7-1.8) 1.0 (0.6-1.7)
15.0-20.0 cm 177 95 (53.7) ref ref
Caretaker’s Education
No formal education 78 64 (82.1) 5.9 (2.5-13.9)* 6.6 (2.7-15.8)*
Primary education 366 212 (57.9) 1.8 (0.9-3.5) 2.0 (1.0-4.0)*
Post-primary education 39 17 (43.6) ref ref
Caretaker’s SES
Low 174 106 (60.9) 1.6 (1.0-2.7)* 1.5 (0.9-2.6)
Middle 217 142 (65.4) 1.9 (1.2-3.2)* 1.9 (1.2-3.2)*
High 91 45 (49.5) ref ref
No. of own alive children
1 child 137 69 (50.4) ref ref
2-3 children 240 149 (62.1) 1.6 (1.1-2.5)* 1.7 (1.1-2.7)*
4 or more children 103 74 (71.8) 2.5 (1.5-4.3)* 2.5 (1.4-4.5)*
Home-hospital travel time
0-59 min 164 81 (49.4) ref ref
60-119 min 136 79 (58.1) 1.4 (0.9-2.2) 1.4 (0.9-2.3)
120+ min 143 99 (69.2) 2.3 (1.4-3.7)* 2.1 (1.3-3.4)*
OR – Unadjusted odds ratio (from bivariate analysis). AOR- Adjusted for child’s Age and Sex, and Caretakers Education and socio-economic status (SES).
* - significant findings.
**- Varying total due to missing cases . MUAC – Mid Upper Arm Circumference.
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On the other hand, caretaker’s SES and travel time to dis-
trict hospital was associated with severity of pneumonia
and diarrhoea but not with severity of malaria. Use of a
nearer PHC facility was the only factor that was found to
be significantly associated with disease severity from all
the three diseases.
SP (sulphadoxine-pyrimethamine or FansidarW, formerly
first line anti-malaria drug) was reported by 19 caretakers
as the only drug provided to their children for the treat-
ment of malaria (suspected or confirmed by tests). Five
caretakers reported receiving this drug from public facil-
ities, 6 from drug shops, 7 from private hospitals and 1
from unknown source. Eight out of nine children who
received SP and who were confirmed having malaria by
tests at the district hospital, had presented with severe
malaria, two of them died. SP use for confirmed malaria
treatment was highly associated with severe malaria; 89%
of children treated with SP had presented with severe mal-
aria compared to only 42% among those who had not
received SP (P< 0.01).
Discussion
In this study from rural Tanzania, we found that chil-
dren had a higher probability of presenting at the district
hospital with severe disease if they had utilized PHC fa-
cilities for the same illness, had obtained the first
treatment other than paracetamol from local sources
and drug shops, and if they had received SP as the only
treatment for malaria. Presenting with severe disease
was also associated with caretakers’ low level of educa-
tion and poor nutritional status of children.
An increased risk of severe disease among children of
caretakers who reported having utilized their nearer
PHC facilities for the same illness might have resulted
from selection bias. Caretakers of children who
improved after having utilized PHC facilities obviously
needed not to come to the district hospital. In addition
to that, caretakers of children with severe disease who
do not recover after utilizing PHC facilities might be
more often referred to and seen at the district hospitals
than those with severe disease who do not seek care at
PHC facilities. However it is worth noting that, the ma-
jority of caretakers who reported having utilized their
nearer PHC facilities had obtained the first treatment
other than paracetanol much later (on the third day or
later) as compared to those who did not utilize them.
Delays in treatment initiation among PHC users could
be explained by the reported frequent shortages of
drugs at these facilities [13], also reported in the study
area [14]. Unavailability of drugs at PHC facilities may
result in delays of several days, from the time drugs are
prescribed until when caretakers are able to purchase
Table 2 Multiple logistic regression of potential care-seeking risk factors for severe disease among studied children
(n =483)






1-2 days 246 121 (49.2) ref ref
3-4 days 137 102 (74.5) 3.0 (1.9-4.8)* 2.9 (1.8-4.7)*
5 or more days 100 70 (70.0) 2.4 (1.5-4.0)* 2.1 (1.3-3.6)*
First Rx PCM alone for 24 hrs or more
No 299 203 (67.9%) 2.0 (1.3-2.9)* 1.8 (1.2-2.7)*
Yes 170 88 (51.8%) ref ref
Source of first Rx other than PCM
Home/local or drug shop 123 95 (77.2) 2.9 (1.8-4.7)* 3.2 (1.9-5.2)*
Private hospital 25 16 (64.0) 1.5 (0.7-3.5) 1.9 (0.8-4.8)
Public hospital 330 178 (53.9) ref ref
Local herbs use
No 433 259 (59.8) ref ref
Yes 50 34 (68.0) 1.4 (0.8-2.7) 1.4 (0.7-2.8)
Use of nearer PHC facility
No 191 93 (48.7) ref ref
Yes 132 110 (83.3) 5.3 (3.1-9.0)* 5.2 (3.0-9.1)*
OR – Unadjusted odds ratio (from bivariate analysis). AOR - Adjusted for child’s Age and Sex, and Caretakers Education and socio-economic status (SES).
* - significant findings.
**- Varying total due to missing cases.
PCM=paracetamol. Rx = treatment. PHC=primary health care.
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them from the drug shops. This finding needs further
investigation.
The preference for drugs from local shops as the first
option of care shown in this study is not a new finding
[15-17]. The positive association between obtaining the
first treatment other than paracetamol from these shops
and severe disease in children is worth noting. Drug
shops in Tanzania are very poorly regulated and some of
them sell unregistered and sometimes expired drugs
[18]. On the other hand, the reported use of drugs kept
at home from previous consultations needs further in-
vestigation as this practice could be associated with
treatment failures resulting from the use of expired
drugs. Oral suspensions of some of the commonly pre-
scribed syrups like amoxicillin and cotrimoxazole should
be used only for a maximum of 7 days and then
discarded. Caretakers might be using these syrups for
extended periods of time.
A quarter of our study participants had experienced
at least one child death in the past. This depressing
finding calls for urgent measures to improve the situ-
ation. The high number of deaths among children may
be linked to some of the reported unexpected practices
at PHC facilities in the study area [19], including the
ongoing provision of SP for malaria treatment in chil-
dren. Malaria is still the number one killer of children
below five years in Africa [20], as well as in Tanzania
[21]. Resistance of malaria parasites to SP was com-
monly reported in many parts of Africa as well as Tan-
zania between 1999–2000 [22]. In a study conducted in
2000 in Muheza district (one of our study districts), it
was found that 45% of the patients treated with SP
Table 3 Comparison of potential background risk factors for disease severity among individual diseases (n =483)
Risk factor for disease severity AOR AOR AOR AOR
(All cases) (Malaria cases) (Pneumonia cases) (Diarrhoea cases)
Caretaker’s Education
No formal education 6.6 (2.7-15.8)* 1.8 (0.7-4.7) 3.5 (0.6-21.4)
Primary education 2.0 (1.0-4.0)* } 1.7 (0.7-3.9) 2.2 (0.4-10.6)
Post-primary education ref ref ref
Caretaker’s SES
Low 1.5 (0.9-2.6) 1.2 (0.4-3.7) 1.8 (0.9-3.8) 1.7 (0.6-4.8)
Middle 1.9 (1.2-3.2)* 1.0 (0.4-2.8) 2.2 (1.1-4.2)* 1.2 (0.4-3.5)
High ref ref ref ref
No. of own alive children
1 child ref ref ref ref
2-3 children 1.7 (1.1-2.7)* 3.2 (1.0-10.4)* 0.7 (0.4-1.4) 2.0 (0.8-4.9)
4 or more children 2.5 (1.4-4.5)* 8.5 (2.3-30.6)* 1.5 (0.6-3.3) 1.1 (0.4-3.2)
Home-hospital travel time
0-59 min ref ref ref ref
60-119 min 1.4 (0.9-2.3) 0.4 (0.1-1.5) 1.5 (0.8-2.7) 2.1 (0.7-6.2)
120+ min 2.1 (1.3-3.4)* 0.9 (0.3-2.9) 1.6 (0.9-3.1) 3.9 (1.4-10.9)*
First Rx PCM alone for 24 hrs or more
No 1.8 (1.2-2.7)* 0.9 (0.4-2.2) 1.8 (1.1-3.3)* 1.7 (0.7-4.4)
Yes ref ref ref ref
Source of first Rx other than PCM
Home/local or drug shop 3.2 (1.9-5.2)* 2.4 (1.3-4.5)* 1.2 (0.5-2.8)
Private hospital 1.9 (0.8-4.8) } 1.7 (0.5-5.5) 0.3 (0.1-1.5)
Public hospital ref ref ref
Use of nearer PHC facility
No ref ref ref ref
Yes 5.2 (3.0-9.1)* 4.2 (1.7-10.5)* 5.2 (2.3-11.9)* 4.4 (1.2-15.8)*
AOR- Adjusted for child’s Age and Sex, and Caretakers Education and socio-economic status (SES).
} - Numbers too small to enable any comparison across groups.
* - significant findings.
PCM=paracetamol. Rx = treatment. PHC=primary health care.
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failed to clear their parasitemias to below patency levels
on day 7 [23]. In 2004, the World Health Organization
(WHO) recommended that all countries revise their mal-
aria treatment policies and opt for a combination treat-
ment, preferably an artemisinin-based combination
therapy (ACT) [24]. Hence, Tanzania changed its first-line
treatment for malaria from sulphadoxine-pyrimethamine
(SP) to artemether-lumefantrine (ALuW) in 2005 [25].
With funding from the Global Fund, Tanzania began, in
December 2006, providing ACTs through public and mis-
sion health facilities free of charge to all children under
five years and at a subsidized price for the rest of the
population [26]. Surprisingly, five out of nineteen children
who received SP as the only treatment for malaria
reported having received it from public hospitals.
At the time of this study (2009/2010), subsidized
ALuW was not yet available outside public facilities in
the study area [27]. Hence we predict that SP use for
malaria treatment at the community level could be even
higher than we have reported in this hospital – based
study, and even much higher among caretakers who do
not utilize public health facilities (not represented in
this study). Further research is needed to ascertain the
extent to which this drug is still in use for malaria
treatment in children, as this drug was highly associated
with severe malaria and death in our sample of
children.
Availability of ACT products in the private sector has
generally been limited to registered pharmacies in urban
areas where the price of a course of therapy is around 8–
10 U.S. dollars [28]. The new treatment is well beyond
the reach of individuals living in rural and peri-urban
communities who need them the most. This has left mil-
lions of Tanzanians in rural areas, including the study
area, to rely on public sector facilities for access to the
recommended first-line treatment for malaria. If they
seek treatment from other sources they may end up re-
ceiving suboptimal therapies, such as SP, which is more
affordable and widely available. However, a few care-
takers in our study had reported to occasionally having
bought the specially packed subsidized ALuW for public
facilities in their nearby local drug shops when these
drugs were out of stock at their nearby PHC facilities.
This finding raises an alarm.
There have been efforts to make subsidized ACTs
available through Accredited Drug Dispensing Outlets
(ADDOs) after realizing an important role played by this
sector in provision of malaria treatment [28]. In 2007,
using funding from the President's Malaria Initiative
(PMI) and technical support from Rational Pharmaceut-
ical Management Plus (RPM Plus) Program, Tanzania
Food and Drugs Authority (TFDA) and National Malaria
Control Programme (NMCP) began a pilot program to
make subsidized ACTs available through ADDOs in 10
districts of Morogoro and Ruvuma regions [28]. The pro-
gram resulted in a gradual increase in the number of
malaria patients treated with ACTs, from 3% of all anti-
malarials sold in July 2007 to 26% in June 2008. At the
same time, the use of non-ACT antimalarials like SP
declined. Currently, the government of Tanzania is trying
to expand the provision of the subsidized ALuW through
ADDOs countrywide.
In line with our findings, several previous studies had
established severe disease to be more common among
younger children and children of caretakers with lower
level of education and SES [3,29,30]. In one hospital-
based study conducted in southern Kerala, India, they
found that severe pneumonia was less frequent in chil-
dren over 2 years [30]. Likewise in our study severe dis-
ease was found to be more common in children less
than two years as compared to those aged two years and
above. In the Indian study above [30], paternal and ma-
ternal education of up to middle school and above was
found to be protective against development of severe
pneumonia. Similarly, our study showed an inverse asso-
ciation between severe disease and caretakers’ level of
education. One community-based study in rural south-
ern Tanzania found that it was more likely for caretakers
with higher SES to seek care from an appropriate pro-
vider as compared to those with lower SES [8]. In the
same study, the frequency of antibiotic use for probable
pneumonia among children with the lowest SES was less
than half of those with the highest SES, and children in
the lowest SES group were half as likely to have been
given antimalarials as those in the highest SES category.
The observed positive association between severe dis-
ease and more number of children may be due to con-
founding; explained by the fact that caretakers with low
education and SES also tend to have more children.
However, the association persisted even after controlling
for education and SES. This finding needs more investi-
gation as it could provide another target group for the
fight towards child mortality from treatable illnesses.
Methodological strengths and limitations
The present study has reported factors associated with
severe disease from the three main childhood killers
(malaria, pneumonia and diarrhea), thus providing more
areas for further intervention towards child mortality
from treatable illnesses. This study inquired care-seeking
information related to the current child illness. By using
this approach, we believe we minimized recall bias as we
were able to pick up easily forgettable care-seeking in-
formation which community based studies may miss,
often relying on past illness episodes of preceding weeks.
Our study was hospital-based and was conducted at
district referral hospitals because this was the most con-
venient way to study factors associated with severe
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disease. To avoid the selection bias, the study should
ideally have been community-based, including all chil-
dren with the three diseases in the area. However, it
would be very difficult to identify and include a high
enough number of severely ill children at the community
level. Hence, we acknowledge that we missed mild and
severe cases that used other options of care and did not
come to the district hospitals. However, biased associa-
tions would only arise if an interaction is present be-
tween severity of disease and potential predictors in
relation to the frequency of seeking hospital care. As dis-
cussed above, this might be the case when attending
PHC facilities is studied as a risk factor, but seems less
likely to influence the findings of the other predictors.
Furthermore, our findings are similar to findings from
previously community-based studies on risk factors for
early childhood deaths [8,31,32].
Thirty seven children had more than one diagnoses; one
child had all three diagnoses. We do not think this influ-
enced our findings significantly as the number of children
with more than one severe disease was very small. The
fact that we did not include caretakers of fifteen children
who died before the interviews could be conducted could
have biased our findings towards milder disease. However
since the number is too small we think the bias should be
minimal.
Conclusions
Our study has identified some factors that are associated
with severity of disease from malaria, pneumonia and
diarrhea. We argue that health interventions addressing
the factors and risk groups identified in this study would
be important for further reduction of child mortality
from treatable illnesses. The findings also indicate the
strong need for district health systems strengthening, in-
cluding strict regulations and close quality monitoring of
the available PHC facilities and drug shops. Further
studies are needed for providing more evidence of the
ways and extent by which low quality of services at the
existing PHC facilities and drug shops contribute to high
mortality among children in developing countries.
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